Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000966526 | SCV001113860 | likely benign | Very long chain acyl-CoA dehydrogenase deficiency | 2024-01-08 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000966526 | SCV001781302 | uncertain significance | Very long chain acyl-CoA dehydrogenase deficiency | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002391010 | SCV002703590 | likely benign | Inborn genetic diseases | 2019-09-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV003311926 | SCV004010552 | likely benign | not provided | 2023-05-01 | criteria provided, single submitter | clinical testing | ACADVL: BP4, BP7 |
Natera, |
RCV000966526 | SCV002088803 | likely benign | Very long chain acyl-CoA dehydrogenase deficiency | 2020-10-16 | no assertion criteria provided | clinical testing |